Keywords: MAPK; ACN; acetonitrile; BTP-M; black-tea-process-mature; CQAs; caffeoylquninic acid; 3-CQA; 3-caffeoylquninic acid; 4-CQA; 4-caffeoylquninic acid; 5-CQA; 5-caffeoylquninic acid; COX-2; cyclooxygenase 2; 3,4-diCQA; 3,4-dicaffeoylquninic acid; 3,5-diCQA; 3,5-dic
مقالات ISI MAPK (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MAPK; AP-1; activator protein 1; DAMP; damage associated molecular patterns; IRAK1; interleukin-1 receptor associated kinase-1; LBP; LPS binding protein; LPS; lipopolysaccharide; MAPK; mitogen-activated protein kinase; MD2; myeloid differentiation factor 2; MHC
Keywords: MAPK; Bone morphogenetic protein (BMP); Granulosa cells; Metformin; Smad and steroidogenesis; ActRII; activin type-II receptor; ALK; activin receptor-like kinase; AMPK; AMP-activated protein kinase; BMP; bone morphogenetic protein; BMPRII; BMP type-II receptor;
Keywords: MAPK; Biomarker; Kidney; Tubular injury; Urine; AKI; acute kidney injury; CKD; chronic kidney disease; DKD; diabetic kidney disease; eGFR; estimated glomerular filtration rate; ERK; extracellular signal-regulated kinase; ESRD; end-stage renal disease; FcαRI/CD
Keywords: MAPK; H2-DCFH-DA; 2â²,7â²-dichlorofluorescein diacetate; iNOS; inducible nitric oxide synthase; MAPK; mitogen activated protein kinase; NF-kB; nuclear factor kappa-light-chain-enhancer of activated B cells; NO; nitric oxide; IBD; Inflammatory bowel diseases;
Keywords: MAPK; ATP; adenosine triphosphate; BES; biolimus-eluting stents; BMS; bare-metal stent; cGMP; cyclic guanosine monophosphate; DES; drug-eluting stents; DRP 1; dynamin-related protein 1; EES; everolimus eluting stent; eNOS; endothelial NOS; FAD; flavin adenine d
Keywords: MAPK; BALF; bronchoalveolar lavage fluid; COPD; chronic obstructive pulmonary disease; CS; cigarette smoke; CSE; cigarette smoke extract; LAMA; long-acting muscarinic receptor antagonists; MIP-2; macrophage inflammatory protein-2; MAPK; mitogen-activated protei
Keywords: MAPK; Caffeoylquinic acid; Hyperglycemia; Propolis; Vascular morphology; p-CA; p-coumaric acid; CGA; chlorogenic acid; MAPK; mitogen-activated protein kinase; NAC; N-acetyl cysteine; PTU; 1-phenyl-2-thiourea; qPCR; quantitative PCR; ROP; retinopathy of prematur
Keywords: MAPK; ATG; autophagy-related proteins; CMA; chaperone-mediated autophagy; ULK1; Unc-51-like kinase 1; PI3K; phosphatidylinositol 3-kinase; mTOR; mammalian target of rapamycin; PE; phosphatidylethanolamine; IFN-γ; interferon-γ; IL-1; interleukin-1; IL-17; inte
Keywords: MAPK; COPD; chronic obstructive pulmonary disease; O3; ozone; BUD; budesonide; BALF; bronchoalveolar lavage fluid; MMP; matrix metalloproteinase; HIF-1α; hypoxia-inducible factor-1α; VEGF; vascular endothelial growth factor; α-SMA; α-smooth muscle actin; GS
Keywords: MAPK; Thymic stromal lymphopoietin; Cysteine; Human mast cell; Caspase-1; Nuclear factor-κB; Abs; antibodies; ANOVA; analysis of variance; AR; allergic rhinitis; BCA; bicinchoninic acid; ELISA; enzyme-linked immunosorbent assay; ERK; extracellular signal-r
Keywords: MAPK; DOHaD; Lead; MAPK; Sex differences; Transcriptomics; Zebrafish;
Keywords: MAPK; Oral squamous cell carcinoma; Head and neck cancer; Tongue cancer; OPLS-DA; Tissue proteomics; CA1; S100A7; Neutrophil defensin 1; ANP32B; Immunohistochemistry; ALYREF; THO complex subunit 4; ANP32B; Acidic leucine-rich nuclear phosphoprotein 32 family me
Keywords: MAPK; AVP; arginine vasopressin; CRF; corticotropin releasing factor; CRFR; corticotropin-releasing factor receptor; dm; dorsolateral magnocellular; dp; dorsal parvocellular; eGFP; enhanced green fluorescent protein; ERK; extracellular signal-regulated kinase;
Keywords: MAPK; Resistin-like molecule; Macrophage; Helminth infection; T helper type 2; Toll-like Receptor 4; ABC; ATP-binding cassette transporter; ADD1; adipocyte determination and differentiation dependent factor 1; ADSF; adipocyte secreted factor; Akt (aka PKB); pro
Keywords: MAPK; 2,5-DXP; 2,5-diketopiperazine; ACC; adenoid cystic carcinomas; BBR; berberine; BET; bromodomain and extraterminal; CA; chebulagic acid; CPT; camptothecin; EMT; epithelial-mesenchymal transition; GSK3; glycogen synthase kinase 3-; HCC; hepatocellular carci
Keywords: MAPK; TSLP; Thymic stromal lymphopoietin; LXR; Liver X receptor; RXR; retinoid X receptor; RAR; retinoic acid receptor; PPAR; peroxisome proliferator-activated receptor; VDR; vitamin D receptor; GR; glucocorticoids receptor; 22R-HC; 22(R)-hydroxycholesterol;
Keywords: MAPK; BB; bevacizumab-bevacizumab; BP; bevacizumab followed by panitumumab; CA9; carbonic anhydrase 9; CRC; colorectal cancer; DEGs; differentially expressed genes; EGFR; epidermal growth factor receptor; EPHA2; ephrin type-A receptor 2; FASN; fatty acid syntha
Keywords: MAPK; ABC; ATP-binding cassette; AKT; V-Akt murine thymoma viral oncogene homolog; ALDH1; aldehyde dehydrogenase 1; AR; androgen receptor; Bad; Bcl-2-associated death promoter; Bak; Bcl-2 homologous antagonist killer; Bax; Bcl-2-associated X protein; Bcl-2; B-c
Keywords: MAPK; ACh; acetylcholine; ARO; aromatase; CamKII; calcium/calmodulin-dependent protein kinases; ChAT; choline acetyltransferase; ChEIs; cholinesterase inhibitors; CREB; cAMP response element-binding proteins; DMP; delayed-matching-to-position; ERs; estrogen rec
Keywords: MAPK; Citrus polymethoxyflavones; Metabolic disorder regulation; Anti-inflammation; Neuro-protection; Anti-cancer; ACC; acetyl-coA carboxylase; Akt; protein kinase B; AMPK; AMP-activated protein kinase; BaP; benzo[a]pyrene; C/EBP; CCAAT/enhancer-binding protein
Keywords: MAPK; α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: MAPK; AMPK; AMP-activated protein kinase; BLM; bleomycin; COX 2; cycloxigenase-2; EMT; epithelial mesenchymal transition; GPx; glutathione peroxidase; GST; gluthatione S transferase; HYP; hydroxyproline; IFN-α; interferon alpha; IL; interleukin; JAK-STAT; the
Keywords: MAPK; Air pollution; Obesogenic nutrition; Oxidative stress; Inflammation; Lungs; Nrf2 transcription factor; Methyltransferases; Intra-tracheal instillation; PM; particulate matter; HFD; high fat diet; CVD; cardiovascular disease; ROS; reactive oxygen species;
Keywords: MAPK; ADA; anti-drug antibodies; AMPK; 5â² adenosine monophosphate-activated protein kinase; aHUS; atypical hemolytic uremic syndrome; AMD; age-related macular degeneration; APC; antigen presenting cells; AT; anaphylatoxin; BTK; Bruton's tyrosine kinase; C1q
Keywords: MAPK; ABA; Abscisic acid; AFPs; Antifreeze proteins; AGPs; Arabinogalactan proteins; ATG; Autophagy; CDPKs; Ca2+-dependent protein kinases; CIPKs; CBL-interacting protein kinases; CAX; Ca2+/H+ exchangers; ICE1; Inducer of CBF expression 1; CBFs; C-repeat bindin
Keywords: MAPK; Carcinogenesis; Chemoprevention; Chemotherapy; Oxidative stress; Nrf2; Phytochemicals; AKT; protein kinase B; AMPK; AMP-activated protein kinase; ARE; antioxidant response element; ATF-2; activating transcriptional factor; BBN; N-butyl-N-(4-hydroxybutyl)n
Keywords: MAPK; AgRP; agouti-related protein; AMPK; adenosin monophosphate activated protein kinase; AN; arcuate nucleus; As; arsenic; AraC; cytosine β-D-arabinofuranoside; BDNF; brain derived neurotrophic factor; BPA; bisphenol A; Ca; calcium; cDNA; complementary deoxy
Keywords: MAPK; BALB 3T3; mouse embryonic fibroblast cells; Bn; bombesin; BnR; bombesin receptors; BRS-3; bombesin receptor subtype-3; BSA; bovine serum albumin fraction V; CNS; central nervous system; DMEM; Dulbecco's minimum essential medium; EGFR; epidermal growth f
Keywords: MAPK; Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: MAPK; bZIP; basic-leucine zipper; CA; cold acclimation; CAMTA; CALMODULIN BINDING TRANSCRIPTION ACTIVATOR; CBF; C-repeat binding factor; CDPK; calcium-dependent protein kinase; CIPK; calcineurin B-like protein-interacting protein kinase; COR; cold-regulated gen
Keywords: MAPK; ALP; alkaline phosphatase; BMPs; bone morphogenetic proteins; C/EBPÃ; CCAAT/enhancer binding protein beta; CIA; collagen II induced arthritis; CTD; C-terminal domain; Cx43; connexin43; Cxs; connexins; DMOADs; disease-modifying osteoarthritis drugs; ECM;
Keywords: MAPK; AIS; acute immobilization stress; BDNF; brain-derived neurotrophic factor; BSA; bovine serum albumin; CIS; chronic immobilization stress; CRF; corticotropin-releasing factor; CRFR1; corticotropin-releasing factor receptor 1; DG; dentate gyrus; DOR; delta
Keywords: MAPK; AGE; Advanced glycation end-product; AR; Aldose reductase; ACR; Albumin/creatinine ratio; CTGF; Connective tissue growth factor; DM; Diabetes mellitus; DAG; Diacylglycerol; DN; Diabetic nephropathy; DR; Diabetic retinopathy; DCM; Diabetic cardiomyopathy;
Keywords: MAPK; AD; Alzheimer's disease; PPs; polyphenols; EGCG; epigallocatechin gallate; NFTs; neurofibrillary tangles; ACh; acetylcholine; Aβ; amyloid-beta; APP; amyloid precursor protein; PS-1; presenilin-1; PS-2; presenilin-2; AChE; acetylcholine esterase; Cdk5;
Keywords: MAPK; NASH; NAFLD; HCV; HBV; ROS; AFLD; alcoholic fatty liver disease; AMPK; adenosine monophosate-activated protein kinase; ASH; alcoholic steatohepatitis; ASK1; mitogen-activated protein kinase kinase kinase 5; ATP; adenosine triphosphate; CoA; coenzyme A;
Keywords: MAPK; AMPK; adenosine 5â²-monophosphate (AMP)-activated protein kinase; ANGPTL4; angiopoietin-like protein 4; AX; arabinoxylan; CAZymes; carbohydrate active enzymes; CBMs; carbohydrate-binding modules; CVD; cerebrobascular disease; ERs; estrogen receptors; IL;
Keywords: MAPK; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; Arc; activity-regulated cytoskeletal-association protein; BDNF; bone-derived neurotrophic factor; CaMK; Ca2+/calmodulin-dependent protein kinase; cAMP; cyclic adenosine monophosphate;
Keywords: MAPK; FK228 (PubChem CID: 5352062); PXD101 (PubChem CID: 6918638); SAHA (PubChem CID: 5311); LBH-589 (PubChem CID: 6918837); tubacin (PubChem CID: 6675804); tubastatin A (PubChem CID: 49850262); ACY-1215 (PubChem CID: 53340666); ACY-241 (PubChem CID: 53340426);
Keywords: MAPK; Actin dynamics; Rho GTPases; dendritic spines; postsynapse; Abi-1; Abelson interacting protein 1; Abp1; actin binding protein 1; ACTN4; α-actinin-4; ADF; actin-depolymerizing factor; ADHD; attention deficit/hyperactivity disorder; ADNP; activity-dependen
Keywords: MAPK; PI3K; phosphoinositide 3-kinase; MAPK; mitogen activated protein kinase; mTORC1; mTOR complex 1; GCN2; general control nonderepressible 2; ULK; UNC-5 like autophagy activating kinase; ATG; autophagy related gene; GPCR; G protein coupled receptor; UCPs; un
Keywords: MAPK; EMT; Epithelial to mesenchymal transition; MAPK; Mitogen activated protein kinase; MDSC; Myeloid derived suppressor cells; NETs; Neutrophil extracellular traps; VEGF; Vascular endothelial growth factor; Neutrophil elastase; Myeloid derived suppressor cell
Keywords: MAPK; OLG; oligodendrocyte; CNS; central nervous system; SC; Schwann cell; PNS; peripheral nervous system; MBP; myelin basic protein; PLP; proteolipid protein; P0/MPZ; myelin protein zero; EAE; experimental allergic encephalomyelitis; MS; multiple sclerosis; CN
Keywords: MAPK; SCFA; Inflammation, GPCRs; HDACs; NF-κB; MAPK;
Keywords: MAPK; AGEs; advanced glycation end-products; CAD; coronary artery disease; CRP C; reactive protein; CTGF; connective tissue growth factor; DAG; diacyl glycerol; DCM; diabetic cardio-myopathy; DFU; diabetic foot ulcer; eNOS; endothelial nitric oxide synthase; FO
Keywords: MAPK; Saffron; Safranal; Crocin; MAPK; Endothelial dysfunction;
Keywords: MAPK; 5-LOX; 5-lipoxygenase; AA; arachidonic acid; ANOVA; analysis of variance; AP-1; activating protein-1; CGEN; Brazilian Genetic Heritage Management Council; CIOMS; Council of International Organizations of Medical Sciences; CONCEA; National Council for the
Keywords: MAPK; Phthalates; Breast cancer; Diet; Endocrine disruptor; Estrogenic receptor; EDCs; endocrine disrupting chemicals; DEHP; di(2-ethylhexyl) phthalate; BBzP; butylbenzyl phthalate; DnBP; di-n-butyl phthalate; DMP; dimethyl phthalate; DEP; diethyl phthalate; ME
Keywords: MAPK; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: MAPK; ABCB1; ATP-binding cassette sub-family B member 1; ABCG; ATP-binding cassette drug efflux transporters; ACD; autophagic cell death; AKT; alpha serine/threonine protein kinase; ALDH; aldehyde dehydrogenase; AMPK; AMP-activated protein kinase; AP; apurinic/